The Cooper Companies, Inc. (COO) Stock Analysis
Healthcare · Medical Instruments & Supplies · NasdaqGS
The Cooper Companies, Inc. (COO) posted $4.09B in revenue for fiscal 2025 (up 5.1% year over year), at a 9.2% net margin, and has compounded revenue about 11.0%/yr over five years, per its SEC filings.
Data last refreshed August 2, 2026 from SEC filings · how we compute this
The analyst's take on The Cooper Companies, Inc.
The Cooper Companies, Inc. has grown revenue from $1.97B to $4.09B over the last 10 fiscal years, compounding about 11% a year. The most recent year was up 5.1%, so growth has cooled from its longer-run pace.
Net margin sits at 9.2%, down 0.9 points year over year on a 65.5% gross margin. It carries about $2.50B of total debt.
Synthesised from The Cooper Companies, Inc.'s SEC filings — descriptive, not advice. Ask the analyst your own question →
The Cooper Companies, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.97B | $2.14B | $2.53B | $2.65B | $2.43B | $2.92B | $3.31B | $3.59B | $3.90B | $4.09B |
| Gross profit | $1.17B | $1.37B | $1.63B | $1.76B | $1.53B | $1.96B | $2.14B | $2.36B | $2.60B | $2.68B |
| Net income | $273.90M | $372.90M | $139.90M | $466.70M | $238.40M | $2.94B | $385.80M | $294.20M | $392.30M | $374.90M |
| Net margin | 13.9% | 17.4% | 5.5% | 17.6% | 9.8% | 100.8% | 11.7% | 8.2% | 10.1% | 9.2% |
Source: The Cooper Companies, Inc. SEC filings (10-K). 18 years of history available in the interactive view.
The Cooper Companies, Inc.: no obvious red flags in the filings
Our deterministic scan of the filed statements — receivables vs sales, earnings vs cash, dilution, leverage and margins — didn't flag anything. Ask about the risks →
Explore 18 years of The Cooper Companies, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track COO in your portfolio →
The Cooper Companies, Inc. financial history by metric
Compare The Cooper Companies, Inc. with peers
About The Cooper Companies, Inc.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
The Cooper Companies, Inc. — frequently asked questions
What is The Cooper Companies, Inc.'s revenue?
The Cooper Companies, Inc. (COO) reported revenue of $4.09B for fiscal year 2025, up 5.1% from the prior year, according to its SEC filings.
Is The Cooper Companies, Inc. profitable?
Yes. COO earned net income of $374.90M in fiscal 2025, a net margin of 9.2%.
What is COO's P/E ratio?
The Cooper Companies, Inc. trades at a price-to-earnings ratio of about 61.3 based on the latest data in our nightly-refreshed cache.
How fast is The Cooper Companies, Inc. growing?
COO's revenue grew at roughly 11.0% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does The Cooper Companies, Inc. have?
As of fiscal year 2025, COO carried roughly $2.50B in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is The Cooper Companies, Inc.'s gross margin?
COO's gross margin was 65.5% in fiscal 2025 — gross profit of $2.68B on revenue of $4.09B.
What is The Cooper Companies, Inc.'s market cap?
The Cooper Companies, Inc. (COO) has a market capitalization of about $0, based on the latest data in our nightly-refreshed cache.
When does The Cooper Companies, Inc.'s fiscal year end?
COO's fiscal year ends in October. Its most recent annual filing covers the fiscal year ending 2025-10-31.
Where does this data come from?
All figures are computed from The Cooper Companies, Inc.'s official SEC filings (10-K and 10-Q), covering 18 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.